CTRI/2024/06/068779尚未招募Unknown
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Adenocarcinoma of the Prostate - NI
Pfizer Products India Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients diagnosed and/or treated with mCSPC or mCRPC 01 January 2023 onwards,
- •inclusive. mCSPC is defined as the current and/or historical presence of metastases
- •on any imaging modality sensitive to hormone therapy. mCRPC is defined as the
- •current and/or historical presence of metastases on any imaging modality with
- •evidence of disease progression (a rising PSA or radiographic progression (as defined
- •by the investigator) despite ongoing castration therapy [ADT or prior surgical
- •orchiectomy]).1,9
- •Aged at least 18 years upon diagnosis of mCSPC or mCRPC.
排除标准
- •Previously enrolled in an interventional trial related to metastatic prostate cancer.
研究者
相似试验
尚未招募
Unknown
Real world study of Bladder Cancer patients in IndiaCTRI/2024/06/068713Pfizer Products India Private Limited
尚未招募
Unknown
Scientific data review of prostate cancer patients to study treatment patterns and understand need gaps.CTRI/2024/08/072504Pfizer Limited
已完成
不适用
Real World Treatment Patterns and Clinical Outcomes in Unfit AML Patients Receiving First Line Systemic Treatment or Best Supportive Care (CURRENT)Acute myeloid leukemiaJPRN-UMIN000037786AbbVie Inc.1,762
尚未招募
不适用
Real-world treatment patterns and clinical outcomes among patients with stage I-? non-small cell lung cancer in South KoreaKCT0006723Asan Medical Center4,000
尚未招募
不适用
Clinical presentation, Management, Treatment and Outcome of COVID patientsCTRI/2020/07/026510Hindu Mission Hospital